ResearcherWannan Medical CollegeActive in the last 2 years

Xiaoming Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1494-948X; OpenAlex author ID A5146744083. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

Research progress on the influence of tumor microenvironment on immunotherapy for pancreatic ductal adenocarcinoma. Last author DOI 10.1515/med-2025-1323 ↗
Hollow Cu2MoS4 nanoparticles loaded with immune checkpoint inhibitors reshape the tumor microenvironment to enhance immunotherapy for pancreatic cancer. Co-author DOI 10.1016/j.actbio.2023.10.024 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yuntao YANG · 1 shared paper, 2026 · strength 0.36
- Paper Research progress on the influence of tumor microenvironment on immunotherapy for pancreatic ductal adenocarcinoma. DOI 10.1515/med-2025-1323 ↗
Zhipeng Yao · 1 shared paper, 2024 · strength 0.20
- Paper Hollow Cu2MoS4 nanoparticles loaded with immune checkpoint inhibitors reshape the tumor microenvironment to enhance imm… DOI 10.1016/j.actbio.2023.10.024 ↗
Hongping Xia · 1 shared paper, 2024 · strength 0.20
- Paper Hollow Cu2MoS4 nanoparticles loaded with immune checkpoint inhibitors reshape the tumor microenvironment to enhance imm… DOI 10.1016/j.actbio.2023.10.024 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.